6 February 2018
On January 19, during the midwinter meeting of the Dutch Association of HIV Treatment Professionals, the Martijn Verbrugge Award 2017-2018 was awarded to Pauline Bollen, PhD candidate and hospital pharmacist, within the theme of Infectious diseases and global health.
Pauline received this award for the best abstract of original research on HIV-infected patients. The title of her lecture was: The pharmacokinetics and safety of dolutegravir in HIV-infected pregnant women. The preliminary results from this study show that the plasma concentrations of the new HIV drug dolutegravir do not change significantly during pregnancy, and that the application appears to be effective and safe. These results will contribute to the next update of international guidelines for treatment of HIV-positive women. The research is part of the PANNA network that is led by Dr Angela Colbers and Prof. David Burger (www.pannastudy.com).The award is named after Martijn Verbrugge, AIDS activist and former chairman of the Dutch HIV Association who died of AIDS in 2004.-
Want to know more about these subjects? Click on the buttons below for more news.